Articles By Anuja Singh
Can Harvard’s FaceAge and Emerging AI Facial Recognition Apps Revolutionize Disease Prediction and Personalized…
Key Highlights: AI Facial Recognition as a Medical BiomarkerDeveloped at Harvard Medical School, the FaceAge algorithm analyzes photos…
By
How Will BioNTech’s Patent Settlement Impact the Future of mRNA COVID-19 and Influenza Vaccines…
Key Highlights Resolving Patent Litigation and Securing LicensesBioNTech SE and Pfizer reached agreements with CureVac N.V. and GlaxoSmithKline…
Could Eli Lilly’s AI-Driven Innovation Accelerate Biopharma Growth to $62 Billion in 2025?
Key Highlights Robust Revenue Growth Powered by AI-Driven ProductsIn Q2 2025, Eli Lilly delivered impressive top-line performance with…
Could Chai’s $70 Million OpenAI-Backed Funding Propel the Next Leap in AI-Engineered Drug Discovery Success?
Key Highlights Breakthrough Funding and Industry BackingThe Series A round brings Chai Discovery’s total capital to $100 million,…
Is Illinois’ Ban on AI in Mental Healthcare a Turning Point for Human-Centered Therapy Regulation in the U.S.?
Key Highlights Background and Impetus for the BanDriven by incidents where AI chatbots posed risks—including cases suggesting harmful…
Can Zimmer Biomet’s $177 Million AI-Driven Acquisition of Monogram Technologies Redefine the Future of…
Key Highlights Strategic Acquisition Enhances Zimmer Biomet’s Robotics LeadershipZimmer Biomet’s acquisition of Monogram Technologies, announced in July 2025,…
Can Harvard’s FaceAge and Emerging AI Facial Recognition Apps Revolutionize Disease Prediction and Personalized…
Key Highlights: AI Facial Recognition as a Medical BiomarkerDeveloped at Harvard Medical School, the FaceAge algorithm analyzes photos…
How Will BioNTech’s Patent Settlement Impact the Future of mRNA COVID-19 and Influenza Vaccines…
Key Highlights Resolving Patent Litigation and Securing LicensesBioNTech SE and Pfizer reached agreements with CureVac N.V. and GlaxoSmithKline…
Could Eli Lilly’s AI-Driven Innovation Accelerate Biopharma Growth to $62 Billion in 2025?
Key Highlights Robust Revenue Growth Powered by AI-Driven ProductsIn Q2 2025, Eli Lilly delivered impressive top-line performance with…
Could Chai’s $70 Million OpenAI-Backed Funding Propel the Next Leap in AI-Engineered Drug Discovery Success?
Key Highlights Breakthrough Funding and Industry BackingThe Series A round brings Chai Discovery’s total capital to $100 million,…
Is Illinois’ Ban on AI in Mental Healthcare a Turning Point for Human-Centered Therapy Regulation in the U.S.?
Key Highlights Background and Impetus for the BanDriven by incidents where AI chatbots posed risks—including cases suggesting harmful…
Can Zimmer Biomet’s $177 Million AI-Driven Acquisition of Monogram Technologies Redefine the Future of…
Key Highlights Strategic Acquisition Enhances Zimmer Biomet’s Robotics LeadershipZimmer Biomet’s acquisition of Monogram Technologies, announced in July 2025,…